PT687184E - Adenovirus recombinantes e sua utilizacao em terapia genica para o tratamento de patologias oculares - Google Patents

Adenovirus recombinantes e sua utilizacao em terapia genica para o tratamento de patologias oculares

Info

Publication number
PT687184E
PT687184E PT94908383T PT94908383T PT687184E PT 687184 E PT687184 E PT 687184E PT 94908383 T PT94908383 T PT 94908383T PT 94908383 T PT94908383 T PT 94908383T PT 687184 E PT687184 E PT 687184E
Authority
PT
Portugal
Prior art keywords
treatment
gene therapy
recombinant adenovirus
eye pathologies
pathologies
Prior art date
Application number
PT94908383T
Other languages
English (en)
Inventor
Michel Perricaudet
Pascale Briand
Original Assignee
Aventis Pharma Sa
Inst Nat La Sante Et La Rech M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Inst Nat La Sante Et La Rech M filed Critical Aventis Pharma Sa
Publication of PT687184E publication Critical patent/PT687184E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT94908383T 1993-03-03 1994-02-28 Adenovirus recombinantes e sua utilizacao em terapia genica para o tratamento de patologias oculares PT687184E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9302438A FR2702152B1 (fr) 1993-03-03 1993-03-03 Virus recombinants et leur utilisation en thérapie génique.

Publications (1)

Publication Number Publication Date
PT687184E true PT687184E (pt) 2002-12-31

Family

ID=9444602

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94908383T PT687184E (pt) 1993-03-03 1994-02-28 Adenovirus recombinantes e sua utilizacao em terapia genica para o tratamento de patologias oculares

Country Status (15)

Country Link
EP (1) EP0687184B1 (pt)
JP (1) JP3835809B2 (pt)
AT (1) ATE220923T1 (pt)
AU (1) AU693782B2 (pt)
CA (1) CA2154355A1 (pt)
DE (1) DE69431046T2 (pt)
DK (1) DK0687184T3 (pt)
ES (1) ES2181710T3 (pt)
FR (1) FR2702152B1 (pt)
HU (1) HU218900B (pt)
NO (1) NO319571B1 (pt)
NZ (1) NZ262135A (pt)
PT (1) PT687184E (pt)
WO (1) WO1994020146A1 (pt)
ZA (1) ZA941426B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces
FR2717823B1 (fr) * 1994-03-23 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
IL113052A0 (en) * 1994-03-23 1995-06-29 Rhone Poulenc Rorer Sa Recombinant viruses, their preparation and their use in gene therapy
FR2726575B1 (fr) * 1994-11-09 1996-12-20 Rhone Poulenc Rorer Sa Virus recombinants, preparation et utilisation en therapie genique
FR2717824B1 (fr) * 1994-03-25 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
FR2718150B1 (fr) * 1994-03-29 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
US5827702A (en) 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
US6107027A (en) * 1994-12-14 2000-08-22 University Of Washington Ribozymes for treating hepatitis C
US6696423B1 (en) 1997-08-29 2004-02-24 Biogen, Inc. Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
US6489305B1 (en) 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
EP1246642B1 (fr) * 1999-12-30 2005-09-07 Aventis Pharma S.A. Utilisation d'un vecteur comprenant un acide nucleique codant pour un facteur anti-angiogenique pour le traitement des neovascularisations corneennes
FR2803207B1 (fr) * 1999-12-30 2004-04-30 Aventis Pharma Sa Utilisation d'un vecteur comprenant un acide nucleique codant pour un facteur anti-angiogenique pour le traitement des neovascularisations corneennes
US6821775B1 (en) 2000-02-11 2004-11-23 Genvec, Inc. Viral vector encoding pigment epithelium-derived factor
US20030158112A1 (en) 2002-02-15 2003-08-21 Johns Hopkins University School Of Medicine Selective induction of apoptosis to treat ocular disease
EP1692154A4 (en) 2003-11-24 2009-07-08 Canji Inc REDUCTION OF SKIN TEMPERING
DK2229956T3 (da) 2004-09-13 2013-07-29 Genzyme Corp Multimere konstruktioner
PL2601214T3 (pl) 2010-08-06 2018-05-30 Genzyme Corporation Kompozycje antagonistyczne wobec VEGF oraz ich zastosowania

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336678C (en) * 1988-09-13 1995-08-15 David L. Berliner Prophylaxis and treatment of nervous system diseases with melanin
WO1992017211A1 (en) * 1991-04-05 1992-10-15 Edison Animal Biotechnology Center, Ohio University Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences

Also Published As

Publication number Publication date
NO953329L (no) 1995-08-24
ZA941426B (en) 1994-10-04
JP3835809B2 (ja) 2006-10-18
WO1994020146A1 (fr) 1994-09-15
HU218900B (hu) 2000-12-28
NO953329D0 (no) 1995-08-24
DE69431046T2 (de) 2003-02-13
ATE220923T1 (de) 2002-08-15
EP0687184B1 (fr) 2002-07-24
NO319571B1 (no) 2005-08-29
NZ262135A (en) 2000-12-22
EP0687184A1 (fr) 1995-12-20
CA2154355A1 (fr) 1994-09-15
FR2702152A1 (fr) 1994-09-09
ES2181710T3 (es) 2003-03-01
DK0687184T3 (da) 2002-10-28
DE69431046D1 (de) 2002-08-29
AU6144494A (en) 1994-09-26
FR2702152B1 (fr) 1995-05-24
AU693782B2 (en) 1998-07-09
HUT73215A (en) 1996-06-28
HU9502573D0 (en) 1995-10-30
JPH08509208A (ja) 1996-10-01

Similar Documents

Publication Publication Date Title
PT687184E (pt) Adenovirus recombinantes e sua utilizacao em terapia genica para o tratamento de patologias oculares
DE69630890D1 (de) Peptid-immitierende substanzen in der krebstherapie
FI955552A0 (fi) Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa
FI963696L (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
GR3035440T3 (en) Therapeutic uses of bpi protein products for human meningococcemia
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
ATE247709T1 (de) 3'utr des menschliches prohibitin-gens
NZ299257A (en) Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
DE69821227D1 (de) Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
PT711163E (pt) Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf
ZA93199B (en) An apparatus for use in therapeutic and/or medical treatment.
NO892585D0 (no) Traksjonsapparat e.l. avlastningsapparat for skiver i bumbalryggen for pasienter med ryggsmerter i korsrygg.
SI0751789T1 (en) Gel for treatment of skin diseases and for disinfection of the skin
UA8280A (uk) Спосіб лікування псоріазу